Error
Jump to navigation
Jump to search
There is currently no text in this page. You can search for this page title in other pages, search the related logs, or create this page.
Subcategories
This category has the following 3 subcategories, out of 3 total.
Pages in category "Transfusion medicine"
The following 113 pages are in this category, out of 113 total.
A
C
H
- Hemolytic disease of the newborn
- Hemolytic disease of the newborn (ABO)
- Hemolytic disease of the newborn (anti-Kell)
- Hemolytic disease of the newborn (anti-Rhc)
- Hemolytic disease of the newborn (anti-RhE)
- Hemolytic disease of the newborn (patient information)
- Hemoperfusion
- Hemotherapy
- Hh antigen system
- HIV blood screening
- Human blood group systems
- Human leukocyte antigen
R
- Rh disease
- Rh disease case study one
- Rh disease causes
- Rh disease classification
- Rh disease cost-effectiveness of therapy
- Rh disease differential diagnosis
- Rh disease epidemiology and demographics
- Rh disease future or investigational therapies
- Rh disease historical perspective
- Rh disease history and symptoms
- Rh disease laboratory findings
- Rh disease medical therapy
- Rh disease natural history, complications and prognosis
- Rh disease other diagnostic studies
- Rh disease overview
- Rh disease pathophysiology
- Rh disease physical examination
- Rh disease primary prevention
- Rh disease risk factors
- Rh disease screening
- Rh disease secondary prevention
- Rh incompatibility (patient information)
- Rho(D) Immune Globulin
T
- Transfusion related acute lung injury
- Transfusion-associated graft versus host disease
- Transfusion-associated graft versus host disease (patient information)
- Transfusion-associated graft versus host disease biomarker panel
- Transfusion-associated graft versus host disease case study one
- Transfusion-associated graft versus host disease causes
- Transfusion-associated graft versus host disease chest x ray
- Transfusion-associated graft versus host disease classification
- Transfusion-associated graft versus host disease cost-effectiveness of therapy
- Transfusion-associated graft versus host disease differential diagnosis
- Transfusion-associated graft versus host disease epidemiology and demographics
- Transfusion-associated graft versus host disease future or investigational therapies
- Transfusion-associated graft versus host disease historical perspective
- Transfusion-associated graft versus host disease history and symptoms
- Transfusion-associated graft versus host disease HLA analysis
- Transfusion-associated graft versus host disease laboratory findings
- Transfusion-associated graft versus host disease medical therapy
- Transfusion-associated graft versus host disease natural history, complications and prognosis
- Transfusion-associated graft versus host disease other diagnostic studies
- Transfusion-associated graft versus host disease other imaging findings
- Transfusion-associated graft versus host disease overview
- Transfusion-associated graft versus host disease pathophysiology
- Transfusion-associated graft versus host disease physical examination
- Transfusion-associated graft versus host disease primary prevention
- Transfusion-associated graft versus host disease risk factors
- Transfusion-associated graft versus host disease screening
- Transfusion-associated graft versus host disease secondary prevention
- Transfusion-associated graft versus host disease skin punch biopsy
- Transfusion-associated graft versus host disease surgery
- Transfusion-associated graft versus host disease ultrasound
- Transfusion-related immunomodulation